A brand devoted to clinical research: accuracy and ease of use thanks to years of R&D
A QUICK REMINDER
Due to the lack of standardization in BIA technology, there is substantial variability in the measurements made byinstruments of different manufacturers. This variability has important repercussions on the results of research intobioelectrical impedance, and ultimately impacts on patient care. This issue was highlighted in a recent editorialin the Journal of Cachexia, Sarcopenia and Muscle, written by two authorities of body composition analysis,namely Maria Cristina Gonzales and Steven B. Heymsfield. These authors stressed the need to standardize boththe terminology to describe body compartments and the diagnostic cut-off values for specific populations,considering the particular BIA device used in the reference study.Hence, for reproducible and precise estimates of body composition, it is necessary to use the same BIA instrumentfrom which the reference values are derived.
With more than 4000 studies and over 20.000 users on 5 continents, AKERN instruments are considered by specialists the reference Standard for BIA in the clinical setting and in research.
Since the beginning of BIA analysis, at Akern and RJL Systems, we have played a key role in all the main BIA discoverie, for example, BIA 101 was the first ever device to receive FDA approval, to provide Body Cell Mass (BCM) estimates, to use Phase Angle as a prognostic marker, to detect segmental impedance and to develop BIVA Analysis today all these physiological markers are considered body composition standards ...and our research goes on.
If you have a question, please feel free to contact us!